FDA NDC Directory · JSON-LD · Markdown

Skyrizi

NDC 0074-4059 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namerisankizumab-rzaa
Labeler / ManufacturerAbbVie Inc.
Marketing categoryBiologic License Application · App BLA761105
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsRISANKIZUMAB (55 mg/.37mL)
Marketing started20260612
Package count2

External sources

Source: openFDA. Public-domain (CC0).